Autor: |
Geskin LJ; Department of Dermatology, Columbia University Irving Medical Center, New York, New York. Electronic address: ljg2045@cumc.columbia.edu., Kwinta BD; Columbia University Vagelos College of Physicians and Surgeons, New York, New York., Garcia-Saleem TJ; Department of Dermatology, Columbia University Irving Medical Center, New York, New York., Akilov OE; Cutaneous Lymphoma Program, University of Pittsburgh, Pittsburgh, Pennsylvania., Enz PA; Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Guenova E; Department of Dermatology, Lausanne University Hospital and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Ortiz-Romero PL; Hospital 12 de Octubre, Institute i+12, CIBERONC, Medical School, University Complutense, Madrid, Spain., Papadavid E; Attikon General University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy., Rozati S; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Stonesifer CJ; Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida., Burns A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Stringer WS; Columbia University Vagelos College of Physicians and Surgeons, New York, New York., Tarin E; Service of Dermatology, Hospital 12 de Octubre, Institute i+12, Madrid, Spain., Scarisbrick JJ; Department of Dermatology, University Hospital Birmingham, Birmingham, United Kingdom. |